The aim of our study was to quantify the total anti-SARS-CoV-2 IgM and IgG and IL-6 in human serum from COVID-19 patients and to assess if any of the routine blood tests performed on the first day of hospitalization can predict the extent of the inflammatory response or that of the specific antibody production. Here, IL6 is linked to COVID-19.